Eraloner 25 Mg 20 Tablets

Eraloner 25 Mg 20 Tablets

Description:

Eraloner 25 mg 20 tablets is a prescription cardiovascular medicine containing eplerenone, a selective aldosterone (mineralocorticoid) receptor antagonist. It is primarily used in the management of heart failure and certain types of hypertension, helping to reduce fluid retention and protect the heart by blocking the harmful effects of aldosterone within the renin-angiotensin-aldosterone system (RAAS). Eraloner is formulated as film-coated tablets for oral use and is suitable for adult patients under the supervision of a healthcare professional.

Indications:

• Treatment of chronic heart failure (particularly systolic heart failure) in adults, usually in addition to standard therapy (such as ACE inhibitors, angiotensin receptor blockers, beta-blockers, and diuretics) as prescribed by a doctor.
• Reduction of risk of cardiovascular mortality and hospitalization in patients with heart failure and reduced ejection fraction after a recent myocardial infarction (heart attack), when indicated by a cardiologist.
• Adjunctive therapy in selected cases of hypertension where mineralocorticoid receptor blockade is clinically appropriate, as determined by a physician.
• Helps manage symptoms related to fluid overload such as edema, shortness of breath, and fatigue associated with heart failure, when used as part of a comprehensive treatment plan.

Active Ingredients / Key Components:

• Eplerenone – 25 mg per film-coated tablet.
• Excipients: The full list of inactive ingredients (tablet core and film-coating components, such as fillers, binders, colorants, and coating agents) is not available in the provided information. Please refer to the official package leaflet for a complete excipient list.

Dosage & Administration / How to Use:

• Eraloner 25 mg tablets are for oral use only and should be taken exactly as prescribed by your doctor.
• Tablets may be taken with or without food, swallowed whole with a sufficient amount of water. Do not crush or chew unless your doctor advises otherwise.
• Typical starting dose and titration schedule for heart failure or post-myocardial infarction therapy depend on kidney function, serum potassium levels, and concomitant medications. The exact dose (for example, 25 mg once daily, then possibly increased) must be determined by the prescribing physician.
• Your doctor will regularly monitor your blood potassium and kidney function (serum creatinine, eGFR) and may adjust the dose or discontinue treatment based on these results.
• If you miss a dose, take it as soon as you remember on the same day. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not double the dose to make up for a missed tablet.
• Do not stop taking Eraloner suddenly without consulting your doctor, as this may worsen your heart condition.

Clinical Benefits:

• Helps reduce morbidity and mortality in selected patients with heart failure and reduced ejection fraction, especially after myocardial infarction, when used as part of guideline-directed medical therapy.
• Decreases the harmful effects of aldosterone on the heart and blood vessels, contributing to improved cardiac remodeling and long-term cardiovascular protection.
• Assists in controlling fluid balance and reducing symptoms related to fluid overload, such as swelling of the legs and shortness of breath, when combined with other heart failure medications.
• Provides a more selective mineralocorticoid receptor blockade compared with some older agents, which may result in fewer endocrine-related side effects (such as gynecomastia) than spironolactone, while maintaining effective aldosterone antagonism.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to eplerenone or any of the excipients.
• Contraindicated in patients with severe kidney impairment or anuria, and in those with clinically significant hyperkalemia (high blood potassium levels) at baseline.
• Contraindicated in patients with severe hepatic impairment unless specifically evaluated and monitored by a specialist.
• Use with caution in patients with mild to moderate kidney impairment, diabetes with kidney disease, or those taking other medicines that increase potassium (such as ACE inhibitors, ARBs, potassium-sparing diuretics, potassium supplements, or certain NSAIDs). Frequent monitoring of serum potassium is essential.
• Concomitant use with strong CYP3A4 inhibitors (such as ketoconazole, itraconazole, certain macrolide antibiotics, some antivirals, and grapefruit products) may significantly increase eplerenone levels and should be avoided unless directed and monitored by a physician.
• Consult your doctor before use if pregnant or planning pregnancy. Eplerenone should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus.
• Consult your doctor before use if breastfeeding. It is not known with certainty whether eplerenone is excreted in human milk; your doctor may advise to discontinue breastfeeding or the drug.
• Inform your doctor about all medications you are taking, including over-the-counter drugs, herbal supplements, and salt substitutes containing potassium.
• Patients with liver disease, kidney disease, diabetes, dehydration, or low blood pressure should be closely monitored.
• May cause dizziness or lightheadedness; caution is advised when driving or operating machinery until you know how the medicine affects you.
• Not intended to diagnose, treat, cure, or prevent any disease without medical supervision; it is a prescription medicine that must be used under a doctor’s direction.
• Keep out of reach of children.

Side Effects:

• Common side effects may include increased blood potassium levels (hyperkalemia), dizziness, low blood pressure (hypotension), fatigue, headache, and mild gastrointestinal symptoms such as nausea or diarrhea.
• Laboratory abnormalities may include changes in kidney function tests (increased creatinine, decreased eGFR) and electrolyte disturbances, especially elevated potassium.
• Less common side effects can include palpitations, muscle cramps, cough, or rash. Endocrine-related side effects such as breast tenderness or gynecomastia are generally less frequent than with spironolactone but can still occur.
• Serious side effects: severe hyperkalemia (which may present with muscle weakness, irregular heartbeat, or chest pain), marked deterioration in kidney function, severe dizziness or fainting due to low blood pressure, or signs of allergic reaction (swelling of face, lips, tongue, difficulty breathing, severe rash). Seek immediate medical attention if any of these occur.
• Report any persistent or bothersome side effects to your doctor or pharmacist for assessment and possible dose adjustment.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.

Specifications:

• Active ingredient: eplerenone 25 mg per film-coated tablet.
• Form: film-coated tablet for oral administration.
• Pack size: 20 tablets per pack.
• Intended use: prescription cardiovascular medicine for adults, used under medical supervision for heart failure and related cardiovascular indications.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.